Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Patient-Derived Organoids of Cholangiocarcinoma
Christopher Maier, Lei Zhu, Lahiri Kanth Nanduri, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 16, pp. 8675-8675
Open Access | Times Cited: 45

Showing 1-25 of 45 citing articles:

Organoids: The current status and biomedical applications
Siqi Yang, Hai‐Jie Hu, Heng‐Chung Kung, et al.
MedComm (2023) Vol. 4, Iss. 3
Open Access | Times Cited: 105
Organoid cultures for cancer modeling
Helen H.N. Yan, April Chan, Frank Pui-Ling Lai, et al.
Cell stem cell (2023) Vol. 30, Iss. 7, pp. 917-937
Open Access | Times Cited: 47
Modelling immune cytotoxicity for cholangiocarcinoma with tumour-derived organoids and effector T cells
Guoying Zhou, Ruby Lieshout, Gilles van Tienderen, et al.
British Journal of Cancer (2022) Vol. 127, Iss. 4, pp. 649-660
Open Access | Times Cited: 54
Human liver cancer organoids: Biological applications, current challenges, and prospects in hepatoma therapy
Lichan Chen, Xiafei Wei, Dayong Gu, et al.
Cancer Letters (2023) Vol. 555, pp. 216048-216048
Closed Access | Times Cited: 33
Integration of pan-omics technologies and three-dimensional in vitro tumor models: an approach toward drug discovery and precision medicine
Anmi Jose, Pallavi Kulkarni, Jaya Thilakan, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 15
Global Literature Analysis of Tumor Organoid and Tumor-on-Chip Research
Jun‐ya Shoji, Richard P. Davis, Christine L. Mummery, et al.
Cancers (2025) Vol. 17, Iss. 1, pp. 108-108
Open Access | Times Cited: 1
Exploring the effects of gut microbiota on cholangiocarcinoma progression by patient-derived organoids
Ann‐Kathrin Lederer, Nele Görrissen, Tinh Thi Nguyen, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 1
Organoids and spheroids: advanced in vitro models for liver cancer research
Mirella Pastore, A. Giachi, Elena Spínola-Lasso, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 12
Open Access | Times Cited: 1
State-of-the-Art Liver Cancer Organoids: Modeling Cancer Stem Cell Heterogeneity for Personalized Treatment
Julien Giron‐Michel, Maël Padelli, Estelle Oberlin, et al.
BioDrugs (2025)
Open Access | Times Cited: 1
The importance of preclinical models for cholangiocarcinoma drug discovery
Florian Primavesi, Felix J. Krendl, Rupert Oberhuber, et al.
Expert Opinion on Drug Discovery (2025)
Closed Access | Times Cited: 1
Integrative analysis of multiple genomic data from intrahepatic cholangiocarcinoma organoids enables tumor subtyping
Hee Seung Lee, Dai Hoon Han, Kyungjoo Cho, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 22
Liver Organoids as an In Vitro Model to Study Primary Liver Cancer
Silvia De Siervi, Cristian Turato
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4529-4529
Open Access | Times Cited: 16
From Non-Alcoholic Fatty Liver Disease to Liver Cancer: Microbiota and Inflammation as Key Players
Avilene Rodríguez‐Lara, Ascensión Rueda‐Robles, María José Sáez‐Lara, et al.
Pathogens (2023) Vol. 12, Iss. 7, pp. 940-940
Open Access | Times Cited: 13
Liver organoids: a promising three-dimensional model for insights and innovations in tumor progression and precision medicine of liver cancer
Yukun Chen, Yujun Liu, Shimin Chen, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 13
Patient-derived models facilitate precision medicine in liver cancer by remodeling cell-matrix interaction
Kaiwen Chen, Yanran Li, Bingran Wang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 12
The utilisation of biliary organoids for biomedical applications
Zhongwen Lei, Yijun Yang, Yang Xiang
Frontiers in Bioengineering and Biotechnology (2025) Vol. 12
Open Access
HCG18 Promotes Cell Proliferation and Stemness in Cholangiocarcinoma via the miR-194-5p/KRT18/MAPK Signaling
Guodong Tian, Lu Zuo, Jie Li, et al.
Biochemical Genetics (2025)
Closed Access
Management of intrahepatic cholangiocarcinoma: a review for clinicians
Matteo Colangelo, Marcello Di Martino, Michela Anna Polidoro, et al.
Gastroenterology report (2025) Vol. 13
Open Access
Molecular subtypes of intrahepatic cholangiocarcinoma
A. De Santis, Lei Zhu, Jianxin Tao, et al.
Trends in Molecular Medicine (2025)
Open Access
3D tumor cultures for drug resistance and screening development in clinical applications
Zheng Peng, Xiaolan Lv, Hao Sun, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access
Human Hepatobiliary Organoids: Recent Advances in Drug Toxicity Verification and Drug Screening
H. Fang, Haoying Xu, Jiong Yu, et al.
Biomolecules (2024) Vol. 14, Iss. 7, pp. 794-794
Open Access | Times Cited: 3
Hepatobiliary organoid research: the progress and applications
Rui-Qi Zou, Yu-Shi Dai, Fei Liu, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
A novel microfluidic self-perfusion chip (MSPC) for pumpless 3D cell, microtissue and organoid culture
Guohua Wu, Di Wu, Wenqi Hu, et al.
Lab on a Chip (2025)
Closed Access
Revolutionizing digestive system tumor organoids research: Exploring the potential of tumor organoids
Zhian Xiu, Qian Yang, Fusheng Xie, et al.
Journal of Tissue Engineering (2024) Vol. 15
Open Access | Times Cited: 2
Exploring tumor organoids for cancer treatment
Hairong Jin, Qian Yang, Jing Yang, et al.
APL Materials (2024) Vol. 12, Iss. 6
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top